Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0038220 (
status epilepticus
)
7,272
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Ischemic stroke causes transient increase of neural stem and progenitor cell (NSPC) proliferation in the subventricular zone (SVZ), and migration of newly formed neuroblasts toward the damaged area where they mature to striatal neurons. The molecular mechanisms regulating this plastic response, probably involved in structural reorganization and functional recovery, are poorly understood. The adaptor protein
LNK
suppresses hematopoietic stem cell self-renewal, but its presence and role in the brain are poorly understood. Here we demonstrate that
LNK
is expressed in NSPCs in the adult mouse and human SVZ.
Lnk
(-/-) mice exhibited increased NSPC proliferation after stroke, but not in intact brain or following
status epilepticus
. Deletion of
Lnk
caused increased NSPC proliferation while overexpression decreased mitotic activity of these cells in vitro. We found that
Lnk
expression after stroke increased in SVZ through the transcription factors STAT1/3.
LNK
attenuated insulin-like growth factor 1 signaling by inhibition of AKT phosphorylation, resulting in reduced NSPC proliferation. Our findings identify
LNK
as a stroke-specific, endogenous negative regulator of NSPC proliferation, and suggest that
LNK
signaling is a novel mechanism influencing plastic responses in postischemic brain.
...
PMID:Adaptor protein LNK is a negative regulator of brain neural stem cell proliferation after stroke. 2249 61